Medical and Pharmaceutical Health Canada approves Zepbound for obstructive sleep apnea in adults with obesity The disorder can cause excessive daytime sleepiness and increase the risk of serious health problems Joseph MortonJune 24, 2026
News Shionogi to buy out Apnimed stake in sleep apnea venture for up to USD$150 million Shionogi will take full ownership and control of the venture’s pipeline Joseph MortonMarch 27, 2026
Sleep Epilepsy drug reduces sleep apnea symptoms by up to 50 per cent in clinical trial Sleeping with a noisy breathing machine remains one of the biggest frustrations for people with obstructive sleep apnea. However, researchers said an older epilepsy... Joseph MortonMarch 13, 2026
AI and Autonomy The Mugglehead technology roundup: sleep technologies Here's a bird's eye view of the sleep technology industry. Joseph MortonAugust 17, 2022